- Report
- August 2025
- 182 Pages
Global
From €3161EUR$3,545USD£2,754GBP
€3512EUR$3,939USD£3,060GBP
- Report
- August 2025
- 185 Pages
Global
From €3161EUR$3,545USD£2,754GBP
€3512EUR$3,939USD£3,060GBP
- Report
- August 2025
- 195 Pages
Global
From €3161EUR$3,545USD£2,754GBP
€3512EUR$3,939USD£3,060GBP
- Report
- August 2025
- 198 Pages
Global
From €3161EUR$3,545USD£2,754GBP
€3512EUR$3,939USD£3,060GBP
- Report
- August 2025
- 188 Pages
Global
From €3161EUR$3,545USD£2,754GBP
€3512EUR$3,939USD£3,060GBP
- Report
- September 2025
- 250 Pages
Global
From €4003EUR$4,490USD£3,488GBP
- Report
- September 2025
- 250 Pages
Global
From €4003EUR$4,490USD£3,488GBP
- Report
- July 2025
- 175 Pages
Global
From €4003EUR$4,490USD£3,488GBP
- Report
- January 2025
- 180 Pages
Global
From €4012EUR$4,500USD£3,496GBP
- Report
- September 2025
- 146 Pages
Global
From €2674EUR$2,999USD£2,330GBP
- Report
- September 2023
- 110 Pages
Global
From €5305EUR$5,950USD£4,622GBP
- Report
- October 2023
- 113 Pages
Global
From €5305EUR$5,950USD£4,622GBP
- Report
- March 2025
- 200 Pages
India
From €2220EUR$2,490USD£1,934GBP
- Report
- June 2024
- 132 Pages
North America
From €3566EUR$4,000USD£3,107GBP
- Report
- March 2024
- 238 Pages
Global
From €5670EUR$6,360USD£4,940GBP
€7088EUR$7,950USD£6,175GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €3530EUR$3,960USD£3,076GBP
€4413EUR$4,950USD£3,845GBP
- Drug Pipelines
- February 2022
- 74 Pages
Global
From €2817EUR$3,160USD£2,455GBP
€3521EUR$3,950USD£3,068GBP
- Report
- May 2024
- 136 Pages
Global
From €5794EUR$6,499USD£5,048GBP
- Report
- October 2023
- 172 Pages
Global
From €4012EUR$4,500USD£3,496GBP
- Report
- November 2021
- 120 Pages
Global
From €2229EUR$2,500USD£1,942GBP
The Urinary Tract Infection Drug market is a subset of the Urological Disorders Drugs market. It is composed of drugs used to treat urinary tract infections (UTIs), which are caused by bacteria entering the urinary tract. These drugs are typically antibiotics, such as sulfonamides, cephalosporins, and fluoroquinolones. They are used to kill the bacteria and reduce the symptoms of the infection. Other drugs, such as antifungals, may also be used to treat UTIs.
The Urinary Tract Infection Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, AstraZeneca, Sanofi, and Novartis. These companies are constantly developing new drugs to treat UTIs, as well as other urological disorders. Show Less Read more
